Financhill
Sell
35

VKTX Quote, Financials, Valuation and Earnings

Last price:
$21.71
Seasonality move :
11.55%
Day range:
$18.92 - $23.64
52-week range:
$18.92 - $81.86
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.95x
Volume:
8.3M
Avg. volume:
4.4M
1-year change:
-68.28%
Market cap:
$2.6B
Revenue:
--
EPS (TTM):
-$1.00

Earnings Data

Next earnings date for VKTX
Apr 24
2025
Most recent earnings per share
-$0.32
Missed by $0.05
(Feb 5/2025)
Consensus Estimate
-$0.27
(Feb 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VKTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 -- -- -- -$0.36 --
04/24/2025 Q1 -- -- -- -$0.31 --
02/05/2025 Q4 -- -- -$0.32 -$0.27 -$0.05
10/23/2024 Q3 -- -- -$0.22 -$0.24 $0.02
07/24/2024 Q2 -- -- -$0.20 -$0.27 $0.07
04/24/2024 Q1 -- -- -$0.26 -$0.28 $0.02
02/07/2024 Q4 -- -- -$0.25 -$0.25 -$0.00
10/25/2023 Q3 -- -- -$0.23 -$0.22 -$0.01
07/26/2023 Q2 -- -- -$0.19 -$0.20 $0.01
04/26/2023 Q1 -- -- -$0.25 -$0.24 -$0.01
02/08/2023 Q4 -- -- -$0.26 -$0.23 -$0.03
10/26/2022 Q3 -- -- -$0.21 -$0.23 $0.02
07/27/2022 Q2 -- -- -$0.23 -$0.21 -$0.02
04/27/2022 Q1 -- -- -$0.21 -$0.19 -$0.02
02/09/2022 Q4 -- -- -$0.16 -$0.19 $0.03
11/03/2021 Q3 -- -- -$0.17 -$0.21 $0.04
07/28/2021 Q2 -- -- -$0.20 -$0.20 -$0.00
04/28/2021 Q1 -- -- -$0.19 -$0.17 -$0.02
02/17/2021 Q4 -- -- -$0.15 -$0.15 $0.00
10/28/2020 Q3 -- -- -$0.13 -$0.15 $0.02
07/29/2020 Q2 -- -- -$0.13 -$0.14 $0.01
04/30/2020 Q1 -- -- -$0.13 -$0.12 -$0.01
02/26/2020 Q4 -- -- -$0.11 -$0.13 $0.02
11/05/2019 Q3 -- -- -$0.08 -$0.12 $0.04
08/01/2019 Q2 -- -- -$0.11 -$0.09 -$0.02
05/02/2019 Q1 -- -- -$0.07 -$0.09 $0.02
03/13/2019 Q4 -- -- -$0.07 -$0.10 $0.03
11/07/2018 Q3 -- -- -$0.11 -$0.12 $0.01
08/09/2018 Q2 -- -- -$0.13 -$0.12 -$0.01
05/09/2018 Q1 -- -- -$0.08 -$0.13 $0.05
03/07/2018 Q4 -- -- -$0.14 -$0.18 $0.04
11/08/2017 Q3 -- -- -$0.22 -$0.20 -$0.02
08/09/2017 Q2 -- -- -$0.21 -$0.19 -$0.02
03/31/2017 Q1 -- -- -$0.23 -$0.18 -$0.05
12/31/2016 Q4 -- -- -$0.18 -$0.22 $0.04

Viking Therapeutics Earnings Questions

  • How Much did Viking Therapeutics Generate in Revenue Last Quarter?

    Viking Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Viking Therapeutics Beat Earnings Last Quarter?

    Viking Therapeutics announced earnings per share of -$0.32 which represents a miss of analyst forecast a -$0.27 per share.

  • Is Viking Therapeutics Profitable?

    Viking Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Viking Therapeutics EPS Next Year?

    Viking Therapeutics's earnings are forecast to decrease from -$1.01 per share to -$0.96 per share next year representing a decrease of -53.69%.

  • When is Viking Therapeutics's Earnings Date?

    Viking Therapeutics's next earnings date is April 24, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Realty Income the Best Dividend Stock to Buy Long-Term?
Is Realty Income the Best Dividend Stock to Buy Long-Term?

Realty Income (NYSE:O) is a longstanding real estate investment trust…

Is Archer Aviation a Buy, Sell or Hold?
Is Archer Aviation a Buy, Sell or Hold?

Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…

Down 50%, Is Dell Technologies a Buy?
Down 50%, Is Dell Technologies a Buy?

Dell (NYSE:DELL)’s share price has been on a roller coaster…

Stock Ideas

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
33
BULZ alert for Apr 10

MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 15.35% over the past day.

Sell
31
TECS alert for Apr 10

Direxion Daily Technology Bear 3x Shares [TECS] is up 12.66% over the past day.

Sell
48
FNGA alert for Apr 10

MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 13.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock